Thyroid hormone signaling in energy homeostasis and energy metabolism

Annals of the New York Academy of Sciences

Volumn 1311, Issue 1, 2014, Pages 77-87

  Mcaninch, Elizabeth A ^a   Bianco, Antonio C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Basal metabolic rate; Cellular metabolism; Deiodinases; Energy homeostasis; Thyroid hormone

Indexed keywords

AGOUTI RELATED PROTEIN; AMINE; LEPTIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; PROTIRELIN; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYRONAMINE; THYROXINE 5 DEIODINASE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

APPETITE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN NERVE CELL; ENERGY; ENERGY HOMEOSTASIS; ENERGY METABOLISM; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; HYPOTHYROIDISM; INSULIN RESISTANCE; OBESITY; SIGNAL TRANSDUCTION; TEMPERATURE; THERMOGENESIS; THYROID HORMONE BLOOD LEVEL;

BASAL METABOLIC RATE; CELLULAR METABOLISM; DEIODINASES; ENERGY HOMEOSTASIS; THYROID HORMONE;

ANIMALS; BASAL METABOLISM; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; OBESITY; RECEPTORS, THYROID HORMONE; THYROID HORMONES;

EID: 84898431030     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12374     Document Type: Article

References (110)

1. Hollenberg, A.N. 2008. The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. Thyroid 18: 131-139.
2. Oppenheimer, J.H., H.L. Schwartz, C.N. Mariash, et al. 1987. Advances in our understanding of thyroid hormone action at the cellular level. Endocr. Rev. 8: 288-308.
3. Andersen, S., N.H. Bruun, K.M. Pedersen & P. Laurberg. 2003. Biologic variation is important for interpretation of thyroid function tests. Thyroid 13: 1069-1078.
4. Vella, K.R., P. Ramadoss, F.S. Lam, et al. 2011. NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. Cell. Metab. 14: 780-790.
5. Rosenbaum, M., R. Goldsmith, D. Bloomfield, et al. 2005. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J. Clin. Invest. 115: 3579-3586.
6. Tseng, Y.H., A.M. Cypess & C.R. Kahn. 2010. Cellular bioenergetics as a target for obesity therapy. Nat. Rev. Drug. Discov. 9: 465-482.
7. Cannon, B. & J. Nedergaard. 2004. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84: 277-359.
8. Nedergaard, J. & B. Cannon. 2010. The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell. Metab. 11: 268-272.
9. Bianco, A.C. & E.A. Mcaninch. 2013. The role of thyroid hormone and brown adipose tissue in energy homeostasis. Lancet Diabetes Endocrinol. 1: 250-258.
10. De Pergola, G., A. Ciampolillo, S. Paolotti, et al. 2007. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin. Endocrinol. (Oxf) 67: 265-269.
11. Brent, G.A. 2012. Mechanisms of thyroid hormone action. J. Clin. Invest. 122: 3035-3043.
12. Gereben, B., A.M. Zavacki, S. Ribich, et al. 2008. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr. Rev. 29: 898-938.
13. Tu, H.M., S.W. Kim, D. Salvatore, et al. 1997. Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138: 3359-3368.
14. Guadano-Ferraz, A., M.J. Obregon, D.L. St Germain & J. Bernal. 1997. The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc. Natl. Acad. Sci. U. S. A. 94: 10391-10396.
15. Kallo, I., P. Mohacsik, B. Vida, et al. 2012. A novel pathway regulates thyroid hormone availability in rat and human hypothalamic neurosecretory neurons. PLoS One 7: e37860.
16. Jo, S., I. Kallo, Z. Bardoczi, et al. 2012. Neuronal hypoxia induces hsp40-mediated nuclear import of type 3 deiodinase as an adaptive mechanism to reduce cellular metabolism. J. Neurosci. 32: 8491-8500.
17. Alkemade, A., E.C. Friesema, U.A. Unmehopa, et al. 2005. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J. Clin. Endocrinol. Metab. 90: 4322-4334.
18. Freitas, B.C., B. Gereben, M. Castillo, et al. 2010. Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J. Clin. Invest. 120: 2206-2217.
19. Visser, W.E., E.C. Friesema & T.J. Visser. 2011. Thyroid hormone transporters: the knowns and the unknowns. Mol. Endocrinol. 25: 1-14.
20. Dumitrescu, A.M., X.H. Liao, T.B. Best, et al. 2004. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Hum. Genet. 74: 168-175.
21. Braun, D., I. Lelios, G. Krause & U. Schweizer. 2013. Histidines in potential substrate recognition sites affect thyroid hormone transport by monocarboxylate transporter 8 (MCT8). Endocrinology 154: 2553-2561.
22. Friesema, E.C., T.J. Visser, A.J. Borgers, et al. 2012. Thyroid hormone transporters and deiodinases in the developing human hypothalamus. Eur. J. Endocrinol. 167: 379-386.
23. Lechan, R.M. & C. Fekete. 2006. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog. Brain Res. 153: 209-235.
24. Coppola, A., Z.W. Liu, Z.B. Andrews, et al. 2007. A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2. Cell. Metab. 5: 21-33.
25. Boelen, A., J. Kwakkel & E. Fliers. 2011. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr. Rev. 32: 670-693.
26. Brown, W.H., M.P. Gillum, H.Y. Lee, et al. 2012. Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism. Proc. Natl. Acad. Sci. U. S. A. 109: 14966-14971.
27. Hernandez, A., M.E. Martinez, S. Fiering, et al. 2006. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J. Clin. Invest. 116: 476-484.
28. Klieverik, L.P., S.F. Janssen, A. van Riel, et al. 2009. Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver. Proc. Natl. Acad. Sci. U. S. A. 106: 5966-5971.
29. Fonseca, T.L., M. Correa-Medina, M.P. Campos, et al. 2013. Coordination of hypothalamic and pituitary T3 production regulates TSH expression. J. Clin. Invest. 123: 1492-1500.
30. Rosene, M.L., G. Wittmann, R. Arrojo e Drigo, et al. 2010. Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment. Endocrinology 151: 5961-5970.
31. Christoffolete, M.A., R. Arrojo e Drigo, F. Gazoni, et al. 2007. Mice with impaired extrathyroidal thyroxine to 3, 5, 3′-triiodothyronine conversion maintain normal serum 3, 5, 3′-triiodothyronine concentrations. Endocrinology 148: 954-960.
32. Lopez, M., L. Varela, M.J. Vazquez, et al. 2010. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat. Med. 16: 1001-1008.
33. Mittag, J., D.J. Lyons, J. Sallstrom, et al. 2013. Thyroid hormone is required for hypothalamic neurons regulating cardiovascular functions. J. Clin. Invest. 123: 509-516.
34. Silva, J.E. & P.R. Larsen. 1983. Adrenergic activation of triiodothyronine production in brown adipose tissue. Nature 305: 712-713.
35. Watanabe, M., S.M. Houten, C. Mataki, et al. 2006. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439: 484-489.
36. da-Silva, W.S., J.W. Harney, B.W. Kim, et al. 2007. The small polyphenolic molecule kaempferol increases cellular energy expenditure and thyroid hormone activation. Diabetes 56: 767-776.
37. da-Silva, W.S., S. Ribich, R. Arrojo e Drigo, et al. 2011. The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure. FEBS Lett. 585: 539-544.
38. Hamada, Y., H. Nagasaki, M. Fuchigami, et al. 2013. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice. Metabolism 62: 734-742.
39. Sagar, G.D., B. Gereben, I. Callebaut, et al. 2007. Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity. Mol. Cell. Biol. 27: 4774-4783.
40. Curcio-Morelli, C., A.M. Zavacki, M. Christofollete, et al. 2003. Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J. Clin. Invest. 112: 189-196.
41. Simonides, W.S., M.A. Mulcahey, E.M. Redout, et al. 2008. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J. Clin. Invest. 118: 975-983.
42. Huang, S.A., M.A. Mulcahey, A. Crescenzi, et al. 2005. Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. Mol. Endocrinol. 19: 3126-3136.
43. Dentice, M., C. Luongo, S. Huang, et al. 2007. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 104: 14466-14471.
44. Dentice, M., A. Bandyopadhyay, B. Gereben, et al. 2005. The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat. Cell. Biol. 7: 698-705.
45. Peeters, R.P., A. Hernandez, L. Ng, et al. 2013. Cerebellar abnormalities in mice lacking type 3 deiodinase and partial reversal of phenotype by deletion of thyroid hormone receptor alpha1. Endocrinology 154: 550-561.
46. Olivares, E.L., M.P. Marassi, R.S. Fortunato, et al. 2007. Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology 148: 4786-4792.
47. Janssen, R., M. Zuidwijk, A. Muller, et al. 2013. Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency microRNA signature from the Dlk1-Dio3 genomic region. Endocrinology 154: 1973-1978.
48. Hall, J.A., S. Ribich, M.A. Christoffolete, et al. 2010. Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis. Endocrinology 151: 4573-4582.
49. Kester, M.H., M.J. Toussaint, C.A. Punt, et al. 2009. Large induction of type III deiodinase expression after partial hepatectomy in the regenerating mouse and rat liver. Endocrinology 150: 540-545.
50. Friesema, E.C., A. Grueters, H. Biebermann, et al. 2004. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364: 1435-1437.
51. Herzovich, V., E. Vaiani, R. Marino, et al. 2007. Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. Horm. Res. 67: 1-6.
52. Wemeau, J.L., M. Pigeyre, E. Proust-Lemoine, et al. 2008. Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J. Clin. Endocrinol. Metab. 93: 2084-2088.
53. Di Cosmo, C., X.H. Liao, H. Ye, et al. 2013. Mct8-deficient mice have increased energy expenditure and reduced fat mass that is abrogated by normalization of serum t3 levels. Endocrinology 154: 4885-4895.
54. Verge, C.F., D. Konrad, M. Cohen, et al. 2012. Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency. J. Clin. Endocrinol. Metab. 97: 4515-4523.
55. Bochukova, E., N. Schoenmakers, M. Agostini, et al. 2012. A mutation in the thyroid hormone receptor alpha gene. N. Engl. J. Med. 366: 243-249.
56. van Mullem, A., R. van Heerebeek, D. Chrysis, et al. 2012. Clinical phenotype and mutant TRalpha1. N. Engl. J. Med. 366: 1451-1453.
57. Moran, C., N. Schoenmakers, M. Agostini, et al. 2013. An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor alpha. J. Clin. Endocrinol. Metab. 98: 4254-4261.
58. Warner, A., A. Rahman, P. Solsjo, et al. 2013. Inappropriate heat dissipation ignites brown fat thermogenesis in mice with a mutant thyroid hormone receptor alpha1. Proc. Natl. Acad. Sci. U. S. A. 110: 16241-16246.
59. Sakurai, A., K. Takeda, K. Ain, et al. 1989. Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc. Natl. Acad. Sci. U. S. A. 86: 8977-8981.
60. Ferrara, A.M., K. Onigata, O. Ercan, et al. 2012. Homozygous thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J. Clin. Endocrinol. Metab. 97: 1328-1336.
61. Ribeiro, M.O., S.D. Bianco, M. Kaneshige, et al. 2010. Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-beta isoform specific and required for adaptive thermogenesis. Endocrinology 151: 432-440.
62. Meruvu, S., S.D. Ayers, G. Winnier & P. Webb. 2013. Thyroid hormone analogues: where do we stand in 2013? Thyroid 23: 1333-1344.
63. Fozzatti, L., D.W. Kim, J.W. Park, et al. 2013. Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor alpha. Proc. Natl. Acad. Sci. U. S. A. 110: 7850-7855.
64. Fozzatti, L., C. Lu, D.W. Kim, et al. 2011. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1). Proc. Natl. Acad. Sci. U. S. A. 108: 17462-17467.
65. Suh, J.H., D.H. Sieglaff, A. Zhang, et al. 2013. SIRT1 is a direct coactivator of thyroid hormone receptor beta1 with gene-specific actions. PLoS. One 8: e70097.
66. Cheng, S.Y., J.L. Leonard & P.J. Davis. 2010. Molecular aspects of thyroid hormone actions. Endocr. Rev. 31: 139-170.
67. Goodson, M.L., B.J. Mengeling, B.A. Jonas & M.L. Privalsky. 2011. Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation. J. Biol. Chem. 286: 44988-44999.
68. Chidakel, A., D. Mentuccia & F.S. Celi. 2005. Peripheral metabolism of thyroid hormone and glucose homeostasis. Thyroid 15: 899-903.
69. Lenzen, S. & C.J. Bailey. 1984. Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans. Endocr. Rev. 5: 411-434.
70. Mouradian, M. & N. Abourizk. 1983. Diabetes mellitus and thyroid disease. Diabetes Care 6: 512-520.
71. Lenzen, S., U. Panten & A. Hasselblatt. 1975. Thyroxine treatment and insulin secretion in the rat. Diabetologia 11: 49-55.
72. Ximenes, H.M., S. Lortz, A. Jorns & S. Lenzen. 2007. Triiodothyronine (T3)-mediated toxicity and induction of apoptosis in insulin-producing INS-1 cells. Life Sci. 80: 2045-2050.
73. Klieverik, L.P., H.P. Sauerwein, M.T. Ackermans, et al. 2008. Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. Am. J. Physiol. Endocrinol. Metab. 294: E513-E520.
74. Taguchi, Y., Y. Tasaki, K. Terakado, et al. 2010. Impaired insulin secretion from the pancreatic islets of hypothyroidal growth-retarded mice. J. Endocrinol. 206: 195-204.
75. Nada, A.M. 2013. Effect of treatment of overt hypothyroidism on insulin resistance. World J. Diabetes. 4: 157-161.
76. Medina, M.C., J. Molina, Y. Gadea, et al. 2011. The thyroid hormone-inactivating type III deiodinase is expressed in mouse and human beta-cells and its targeted inactivation impairs insulin secretion. Endocrinology 152: 3717-3727.
77. Aguayo-Mazzucato, C., A.M. Zavacki, A. Marinelarena, et al. 2013. Thyroid hormone promotes postnatal rat pancreatic beta-cell development and glucose-responsive insulin secretion through MAFA. Diabetes 62: 1569-1580.
78. Mourouzis, I., I. Giagourta, G. Galanopoulos, et al. 2013. Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation. Metabolism 62: 1387-1393.
79. Hong, E.G., B.W. Kim, D. Young Jung, et al. 2013. Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice. Endocrinology 154: 3937-3946.
80. Trivieri, M.G., G.Y. Oudit, R. Sah, et al. 2006. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc. Natl. Acad. Sci. U. S. A. 103: 6043-6048.
81. Heaton, J.M. 1972. The distribution of brown adipose tissue in the human. J. Anat. 112: 35-39.
82. Cypess, A.M., A.P. White, C. Vernochet, et al. 2013. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat. Med. 19: 635-639.
83. Sacks, H. & M.E. Symonds. 2013. Anatomical locations of human brown adipose tissue: functional relevance and implications in obesity and type 2 diabetes. Diabetes 62: 1783-1790.
84. Bianco, A.C., J.D. Kieffer & J.E. Silva. 1992. Adenosine 3′, 5′-monophosphate and thyroid hormone control of uncoupling protein messenger ribonucleic acid in freshly dispersed brown adipocytes. Endocrinology 130: 2625-2633.
85. Sellers, E.A. & S.S. You. 1950. Role of the thyroid in metabolic responses to a cold environment. Am. J. Physiol. 163: 81-91.
86. Bianco, A.C. & J.E. Silva. 1987. Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue. J. Clin. Invest. 79: 295-300.
87. Ribeiro, M.O., F.L. Lebrun, M.A. Christoffolete, et al. 2000. Evidence of UCP1-independent regulation of norepinephrine-induced thermogenesis in brown fat. Am. J. Physiol. Endocrinol. Metab. 279: E314-E322.
88. Young, J.B., E. Saville, N.J. Rothwell, et al. 1982. Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue of the rat. J. Clin. Invest. 69: 1061-1071.
89. Young, J.B., E. Saville & L. Landsberg. 1982. Effect of thyroid state on norepinephrine (NE) turnover in rat brown adipose tissue (BAT): potential importance of the pituitary [Abstract]. Clin. Res. 32: 407.
90. Castillo, M., J.A. Hall, M. Correa-Medina, et al. 2011. Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes 60: 1082-1089.
91. Christoffolete, M.A., C.C. Linardi, L. de Jesus, et al. 2004. Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes 53: 577-584.
92. Feldmann, H.M., V. Golozoubova, B. Cannon & J. Nedergaard. 2009. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell. Metab. 9: 203-209.
93. Ueta, C.B., E.L. Olivares & A.C. Bianco. 2011. Responsiveness to thyroid hormone and to ambient temperature underlies differences between brown adipose tissue and skeletal muscle thermogenesis in a mouse model of diet-induced obesity. Endocrinology 152: 3571-3581.
94. Moriscot, A., R. Rabelo & A.C. Bianco. 1993. Corticosterone inhibits uncoupling protein gene expression in brown adipose tissue. Am. J. Physiol. 265: E81-E87.
95. Poggioli, R., C.B. Ueta, R.A. Drigo, et al. 2013. Dexamethasone reduces energy expenditure and increases susceptibility to diet-induced obesity in mice. Obesity (Silver Spring) 21: E415-420.
96. Apolzan, J.W., G.A. Bray, M.T. Hamilton, et al. 2014. Short-term overeating results in incomplete energy intake compensation regardless of energy density or macronutrient composition. Obesity (Silver Spring) 22: 119-130.
97. Peschechera, A. & J. Eckel. 2013. "Browning" of adipose tissue-regulation and therapeutic perspectives. Arch. Physiol. Biochem. 119: 151-160.
98. Wu, J., P. Cohen & B.M. Spiegelman. 2013. Adaptive thermogenesis in adipocytes: is beige the new brown? Genes. Dev. 27: 234-250.
99. Nomura, E., N. Toyoda, A. Harada, et al. 2011. Type 2 iodothyronine deiodinase is expressed in human preadipocytes. Thyroid 21: 305-310.
100. Lee, J.Y., N. Takahashi, M. Yasubuchi, et al. 2012. Triiodothyronine induces UCP-1 expression and mitochondrial biogenesis in human adipocytes. Am. J. Physiol. Cell. Physiol. 302: C463-C472.
101. Oppenheimer, J.H., H.L. Schwartz, J.T. Lane & M.P. Thompson. 1991. Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. J. Clin. Invest. 87: 125-132.
102. Sinha, R.A., S.H. You, J. Zhou, et al. 2012. Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J. Clin. Invest. 122: 2428-2438.
103. Piehl, S., C.S. Hoefig, T.S. Scanlan & J. Kohrle. 2011. Thyronamines-past, present, and future. Endocr. Rev. 32: 64-80.
104. Scanlan, T.S., K.L. Suchland, M.E. Hart, et al. 2004. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat. Med. 10: 638-642.
105. Chiellini, G., S. Frascarelli, S. Ghelardoni, et al. 2007. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J. 21: 1597-1608.
106. Klieverik, L.P., C.P. Coomans, E. Endert, et al. 2009. Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology 150: 5639-5648.
107. Braulke, L.J., M. Klingenspor, A. Debarber, et al. 2008. 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J. Comp. Physiol. [B]. 178: 167-177.
108. Hackenmueller, S.A., M. Marchini, A. Saba, et al. 2012. Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4. Endocrinology 153: 5659-5667.
109. Hoefig, C.S., J. Kohrle, G. Brabant, et al. 2011. Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay. J. Clin. Endocrinol. Metab. 96: 1864-1872.
110. Piehl, S., T. Heberer, G. Balizs, et al. 2008. Thyronamines are isozyme specific substrates of deiodinases. Endocrinology 149: 3037-3045.